Clinical trial
A Phase 2 Study of Cusatuzumab Plus Azacitidine in Patients With Newly Diagnosed Acute Myeloid Leukemia Who Are Not Candidates for Intensive Chemotherapy
NCT04023526 is registered in ClinicalTrials.gov with OncoVerity, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 2 Study of Cusatuzumab Plus Azacitidine in Patients With Newly Diagnosed Acute Myeloid Leukemia Who Are Not Candidates for Intensive Chemotherapy
- Lead sponsor
- OncoVerity, Inc.
- Phase
- Phase 2
- Overall status
- Active, not recruiting
- Start date
- July 29, 2019
- Completion date
- May 15, 2026
- Enrollment
- 103 (actual)
- Sites
- 56
Conditions
As the registry lists them; a condition with its own page is linked.